Minimal Residual Disease (MRD)-Driven Cessation of Maintenance: Free from Drug Therapy in Multiple Myeloma (FREEDMM trial in progress)

• DOI: 10.1016/j.jtct.2023.12.552
• Publication Date: 2024-02-07T07:39:28Z
• Authors: Ana Avila Rodriguez; Danny Hadidi; Craig Hofmeister; John Quigley; Maria Zappia; Maxim Frolov; Elizaveta V Benev...; Matias Sanchez; Shrihari Kadkol; Douglas Sborov; Damiano Rondelli; Chukwuemeka Uzoka; Karen Sweiss